Exploring the Correlation between Serum Vitamin D Levels and Cancer Stage and Grading in Pediatric Patients

Document Type : original article

Authors

1 Department of Pediatrics, School of Medicine, Iran University of Medical Sciences, Aliasghar Children Hospital, Tehran, Iran.

2 Department of Pediatrics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

3 Department of Emergency Medicine, School of Medicine, Iran University of Medical Sciences, Aliasghar Children Hospital, Tehran, Iran.

4 Department of Pediatric Intensive Care, Iran University of Medical Sciences, Tehan, Iran.

Abstract

Background: Vitamin D deficiency has been linked to an elevated risk of cancer and poor outcomes. This study was conducted to explore the potential impact of vitamin D status on cancer progression and severity in pediatric patients.
Methods: The current study adopted a case-control design to investigate the relationship between serum vitamin D levels and cancer stage and grading in pediatric patients. The case group comprised newly diagnosed cases of children and adolescents with various types of cancer admitted to Ali Asghar Hospital between 2023 - 2024. Statistical analysis was performed using SPSS software version 24, with a significance level set at less than 0.05.
Results: A total of 155 patients were included in the study, with 72 patients in the case group and 86 patients in the control group. Among the participants, 26 (36.1%) and 32 (38.6%) subjects in the case and control groups were girls, respectively. Acute lymphoblastic leukemia (ALL) accounted for 16.1% of the cases, followed by retinoblastoma (5.8%) and acute myeloid leukemia (AML) (4.5%) as the most frequent cancer types observed. Notably, the analysis of vitamin D serum levels revealed no significant difference between the case group (median: 25, range: 76-4) and the control group (median: 27, range: 69.5-12). Furthermore, the comparison of vitamin D serum levels across different cancer stages did not show any significant differences.
Conclusion: Our findings show that children with newly diagnosed cancer have 25 (OH) D3 levels identical to their healthy matches. However, the importance of our findings to cancer progression is unclear and needs further investigations.

Keywords

References

  1. Imtiaz S, Siddiqui N, Raza SA, Loya A, Muhammad A. Vitamin D deficiency in newly diagnosed breast cancer patients. Indian journal of endocrinology and metabolism. 2012 May 1;16(3):409-13.
  2. de Sousa Almeida-Filho B, Vespoli HD, Pessoa EC, Machado M, Nahas-Neto J, Nahas EA. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women. The Journal of steroid biochemistry and molecular biology. 2017 Nov 1;174:284-9.
  3. Karthikayan A, Sureshkumar S, Kadambari D, Vijayakumar C. Low serum 25-hydroxy vitamin D levels are associated with aggressive breast cancer variants and poor prognostic factors in patients with breast carcinoma. Archives of endocrinology and metabolism. 2018 Aug;62(4):452-9.
  4. Palanca A, Ampudia-Blasco FJ, Real JT. The controversial role of vitamin D in thyroid cancer prevention. Nutrients. 2022 Jun 23;14(13):2593.
  5. Niv Y, Sperber AD, Figer A, Igael D, Shany S, Fraser G, et al. In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma. Cancer. 1999 Aug 1;86(3):391-7.
  6. Zhang Q, Sun Y, Zhang C, Qi J, Du J. Vitamin D deficiency and vasovagal syncope in children and adolescents. Frontiers in Pediatrics. 2021 Feb 25;9:575923.
  7. Ren C, Qiu MZ, Wang DS, Luo HY, Zhang DS, Wang ZQ, et al. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. Journal of translational medicine. 2012 Dec;10:1-7.
  8. Dean YE, Elawady SS, Shi W, Salem AA, Chotwatanapong A, Ashraf H, et al. Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients. Endocrinology, Diabetes & Metabolism. 2023 Nov;6(6):e453.
  9. Dzudzor B, Hammond H, Tachi K, Alisi A, Vento S, Gyasi RK, et al. Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design. Health Science Reports. 2023 Feb;6(2):e1101.
  10. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. Journal of Clinical Oncology. 2009 Aug 10;27(23):3757-63.
  11. Lucijanić M, Piskač Živković N, Zelenika M, Barišić-Jaman M, Jurin I, Matijaca A, et al. Survival after hospital discharge in patients hospitalized for acute coronavirus disease 2019: data on 2586 patients from a tertiary center registry. Croatian medical journal. 2022 Aug 25;63(4):335-42.
  12. Süle K, Szentmihályi K, Szabó G, Kleiner D, Varga I, Egresi A, et al. Metal-and redox homeostasis in prostate cancer with vitamin D3 supplementation. Biomedicine & Pharmacotherapy. 2018 Sep 1;105:558-65.
  13. Benarba B, Gouri A. Role of vitamin D in breast cancer prevention and therapy: Recent findings. Journal of Medicine. 2020;21(1):46.
  14. Pilz S, Trummer C, Theiler-Schwetz V, Grübler MR, Verheyen ND, Odler B, et al. Critical appraisal of large vitamin D randomized controlled trials. Nutrients. 2022 Jan 12;14(2):303.
  15. Zhang X, Niu W. Meta-analysis of randomized controlled trials on vitamin D supplement and cancer incidence and mortality. Bioscience reports. 2019 Nov;39(11):BSR20190369.
Journal of Pediatric Perspectives
Volume 12, Issue 11
November 2024
Pages 19152-19157

Files

Share

How to cite

Statistics